W
William P. Arend
Researcher at University of Colorado Denver
Publications - 130
Citations - 26901
William P. Arend is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Receptor & Interleukin 1 receptor antagonist. The author has an hindex of 61, co-authored 130 publications receiving 25520 citations. Previous affiliations of William P. Arend include Anschutz Medical Campus & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Gene G. Hunder,Gene G. Hunder,Daniel A. Bloch,Daniel A. Bloch,Beat A. Michel,Mary Betty Stevens,Mary Betty Stevens,William P. Arend,William P. Arend,Leonard H. Calabrese,Leonard H. Calabrese,Steven M. Edworthy,Steven M. Edworthy,Anthony S. Fauci,Anthony S. Fauci,Randi Y. Leavitt,J. T. Lie,J. T. Lie,Robert W. Lightfoot,Robert W. Lightfoot,Alfonse T. Masi,Alfonse T. Masi,Dennis J. McShane,Dennis J. McShane,John A. Mills,John A. Mills,Stanley L. Wallace,Stanley L. Wallace,Nathan J. Zvaifler,Nathan J. Zvaifler +29 more
TL;DR: Criteria for the classification of giant cell (temporal) arteritis were developed by comparing 214 patients who had this disease with 593 patients with other forms of vasculitis, and 2 other variables were included: scalp tenderness and claudication of the jaw or tongue or on deglutition.
Journal ArticleDOI
The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)
Alfonse T. Masi,Alfonse T. Masi,Gene G. Hunder,Gene G. Hunder,J. T. Lie,J. T. Lie,Beat A. Michel,Daniel A. Bloch,Daniel A. Bloch,William P. Arend,William P. Arend,Leonard H. Calabrese,Leonard H. Calabrese,Steven M. Edworthy,Steven M. Edworthy,Anthony S. Fauci,Anthony S. Fauci,Randi Y. Leavitt,Randi Y. Leavitt,Robert W. Lightfoot,Robert W. Lightfoot,Dennis J. McShane,Dennis J. McShane,John A. Mills,John A. Mills,Mary Betty Stevens,Mary Betty Stevens,Stanley L. Wallace,Nathan J. Zvaifler,Nathan J. Zvaifler +29 more
TL;DR: Criteria for the classification of Churg-Strauss syndrome were developed by comparing 20 patients who had this diagnosis with 787 control patients with other forms of vasculitis, and advantages of the traditional format compared with the classification tree format are discussed.
Journal ArticleDOI
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.
William P. Arend,Beat A. Michel,Daniel A. Bloch,Gene G. Hunder,Leonard H. Calabrese,Steven M. Edworthy,Anthony S. Fauci,Randi Y. Leavitt,J. T. Lie,Robert W. Lightfoot,Alfonse T. Masi,Dennis J. McShane,John A. Mills,Mary Betty Stevens,Stanley L. Wallace,Nathan J. Zvaifler +15 more
TL;DR: Criteria for the classification of Takayasu arteritis were developed by comparing 63 patients who had this disease with 744 control patients with other forms of vasculitis, and the presence of 3 or more of these 6 criteria demonstrated a sensitivity of 90.5% and a specificity of 97.0%.
Journal ArticleDOI
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.
Randi Y. Leavitt,Randi Y. Leavitt,Anthony S. Fauci,Anthony S. Fauci,Daniel A. Bloch,Daniel A. Bloch,Beat A. Michel,Gene G. Hunder,Gene G. Hunder,William P. Arend,William P. Arend,Leonard H. Calabrese,Leonard H. Calabrese,James F. Fries,James F. Fries,J. T. Lie,Robert W. Lightfoot,Robert W. Lightfoot,Alfonse T. Masi,Alfonse T. Masi,Dennis J. McShane,Dennis J. McShane,John A. Mills,John A. Mills,Mary Betty Stevens,Mary Betty Stevens,Stanley L. Wallace,Stanley L. Wallace,Nathan J. Zvaifler,Nathan J. Zvaifler +29 more
TL;DR: Criteria for the classification of Wegener's granulomatosis were developed by comparing 85 patients who had this disease with 722 control patients with other forms of vasculitis with a high level of sensitivity and specificity.
Journal ArticleDOI
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum Charles H,Carol J. Wilcox,William P. Arend,Joslin Fenneke G,David Dripps,Patricia L. Heimdal,Lyman G Armes,Andreas Sommer,Stephen P. Eisenberg,Robert C. Thompson +9 more
TL;DR: Three interleukin-1 inhibitors have been purified to homogeneity from medium conditioned by human monocytes and partial sequence analysis and digestion with N-glycanase indicate that these are glycosylation forms of a single protein.